10-K
REGENERON PHARMACEUTICALS, INC.
- Company
- REGENERON PHARMACEUTICALS, INC.
- Filed
- March 12, 2004
- Period of Report
- December 31, 2003
- Accession Number
- 0000950123-04-003254
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →